Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nerve Growth Factor
36 Products
36 Products
402 Diseases
2102 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Raylumis
(tanezumab) / Eli Lilly, Pfizer
Sentinel
(cenegermin-bkbj) / Dompe
fasinumab
(REGN475) / Teva, Mitsubishi Tanabe, Regeneron
fulranumab
(AMG-403) / Amgen
neublastin
(ARTN) / Biogen
MEDI7352
/ AstraZeneca
liatermin
(r-metHuGDNF) / Parkinson's Society of the United Kingdom
Cogane
(sarsasapogenin) / IXICO
PG-110
/ AbbVie
mercaptopurine delayed release
(DR6MP) / Teva
vandefitemcel
(SB623) / SanBio
ASP6294
/ Astellas
CERE-110
/ Biogen
Ersatta
(mono-pegylated version of C-peptide) / Cebix
LEVI-04
/ Levicept
LM11A-31-BHS
/ PharmatrophiX
NB-01
/ Mthera Pharma
tulrampator
(S47445) / Servier
CXCR2 and NGFR transduced TIL
/ UT MD Anderson Cancer Center
DE-105
/ Santen
EP-9001A
/ Easton Biopharma
Engedi 1000
/ Ensol Biosci
KP544
/ CeNeRx
MEDI-578
/ AstraZeneca
NNI-362
/ NeuroNascent
TAC-302
/ Otsuka, Meiji Seika
